USNA · Usana Health Sciences Inc
$13.37
-0.26 (-1.91%)
At close · Aug 14
Market Cap
$247.03M
Shares
18.48M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$150,000,000
as of 2021-09-16
· not restated in filings since 2021-11-10
Program Utilization
77.3%
$116,000,000 used of $150,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-07-04 YTD | $0 | 10-Q, filed 2026-08-13 |
| 2026-01-03 | $27,507,000 | 10-K, filed 2026-03-16 |
| 2024-12-28 | $9,444,000 | 10-K, filed 2026-03-16 |
| 2023-12-30 | $11,599,000 | 10-K, filed 2026-03-16 |
| 2022-12-31 | $25,382,000 | 10-K, filed 2025-03-12 |
| 2022-01-01 | $177,837,000 | 10-K, filed 2024-02-27 |
| 2021-01-02 | $57,029,000 | 10-K, filed 2023-02-28 |
| 2019-12-28 | $150,000,000 | 10-K, filed 2022-03-01 |
| 2018-12-29 | $105,375,000 | 10-K, filed 2021-03-02 |
| 2017-12-30 | $50,000,000 | 10-K, filed 2020-02-25 |
| 2016-12-31 | $64,610,000 | 10-K, filed 2019-02-26 |
| 2016-01-02 | $61,181,000 | 10-K, filed 2018-02-28 |
| 2015-01-03 | $138,819,000 | 10-K, filed 2017-03-01 |
| 2013-12-28 | $18,085,000 | 10-K, filed 2016-03-01 |
| 2012-12-29 | $68,294,000 | 10-K, filed 2015-03-17 |
| 2011-12-31 | $33,459,000 | 10-K, filed 2014-03-13 |
| 2011-01-01 | $17,031,000 | 10-K, filed 2013-03-11 |
| 2010-01-02 | $1,654,000 | 10-K, filed 2012-03-14 |
Key facts
CIK
896264
CUSIP
90328M107
13F (30d)
129 filings
128 filers
Visit website
Investor relations